An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection
Status:
Completed
Trial end date:
2020-08-13
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate efficacy of 24 weeks of study treatment, in
terms of changes in hepatitis B surface antigen (HBsAg) levels.